How Is Big Pharma Interacting with Tech Startups?
Friday, March 13
12:30PM - 1:30PM
110 E 2nd St
With declining revenues and regulatory hurdles, large pharmaceutical and biotechnology corporations are beginning to look for ways to increase sales of existing drugs and add new sources of revenue. Health IT startups have the potential to solve many of these hurdles, yet on the whole, big pharma has been slow to adopt new innovative technology. This session will look at pharma activity in the the health IT space to date, where it's headed, and what health IT entrepreneurs can do to better appeal to large pharma and biotech.
Life Science Program Mgr
As Life Science Program Manager for Springboard Enterprises, Jennifer Lannon works closely with the Springboard network and entrepreneurs to run the Life Science Accelerator and Dolphin Tank pitch ...Show the rest
As Life Science Program Manager for Springboard Enterprises, Jennifer Lannon works closely with the Springboard network and entrepreneurs to run the Life Science Accelerator and Dolphin Tank pitch events. In the past, Jennifer has worked as a consultant with the Entrepreneur-in-Residence to the NIH through BioHealth Innovation, a non-profit that accelerates the commercialization of market-relevant life science research in central Maryland. She also has first-hand biological research experience in gene therapy as part of her undergraduate honors program (Gemstone). Additionally, Jennifer has always had a passion for female entrepreneurship, which was cultivated further when she served as University of Maryland’s Director of Circle of Sisterhood, a non-profit that recognizes the opportunity to solve many societal issues by advancing the status of women worldwide. She holds a Bachelor of Science in Cell Biology and Genetics from the University of Maryland.Hide the rest